Question 1

How many shares of OVID does BALYASNY ASSET MANAGEMENT L.P. own?

Accepted Answer

As of 2026-Q2, BALYASNY ASSET MANAGEMENT L.P. holds 6.7M shares of OVID (OVID THERAPEUTICS INC).

Question 2

What is BALYASNY ASSET MANAGEMENT L.P.'s OVID position worth?

Accepted Answer

As of 2026-Q2, BALYASNY ASSET MANAGEMENT L.P.'s OVID position is worth $18.1M.

Question 3

Is BALYASNY ASSET MANAGEMENT L.P. buying or selling OVID?

Accepted Answer

In 2026-Q2, BALYASNY ASSET MANAGEMENT L.P. increased their OVID position (+21.4% change in shares).

Question 4

When did BALYASNY ASSET MANAGEMENT L.P. first buy OVID?

Accepted Answer

Based on available 13F filings, BALYASNY ASSET MANAGEMENT L.P. first reported a position in OVID in 2022-Q3. They have held the position across 8 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	6.7M	+21.4%	$18.1M	0.0%	$2.69	34
2026-Q1	Increased	5.5M	+1602.5%	$12.3M	0.0%	$1.70	45
2025-Q4	Decreased	325,000	-48.0%	$529,750	0.0%	$1.63	0
2025-Q3	New	625,000	-	$812,500	0.0%	$1.40	34
2023-Q2	Exited	0	-100.0%	$0	0.0%	$3.32	0
2023-Q1	New	24,056	-	$62,064	0.0%	$2.59	29
2022-Q4	Exited	0	-100.0%	$0	0.0%	$1.86	0
2022-Q3	New	31,938	-	$59,000	0.0%	$1.89	29

OVID8 quarters

OVID
8 quarters